Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Prenetics Global Limited

PRENASDAQ
Healthcare
Medical - Diagnostics & Research
$19.30
$2.25(13.20%)
U.S. Market opens in 17h 12m

Prenetics Global Limited (PRE) Stock Overview

Explore Prenetics Global Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap219.4M
P/E Ratio-4.72
EPS (TTM)$-3.59
ROE-0.36%
Fundamental Analysis

AI Price Forecasts

1 Month$19.65
3 Months$22.78
1 Year Target$20.96

PRE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Prenetics Global Limited (PRE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $20.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.72 and a market capitalization of 219.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-8.45%
5-Day Change
-26.23%
1-Month Change
-15.26%
3-Month Change
23.11%
6-Month Change
115.31%
Year-to-Date (YTD) Change
-1.08%
1-Year Change
193.42%
3-Year Change
-1.82%
5-Year Change
-86.30%
All-Time (Max) Change
-86.30%

Contact Information

852 2210 9588
Unit 701-706, K11 Atelier King’s Road, Quarry Bay, NaN, NaN

Company Facts

2,850 Employees
IPO DateJul 16, 2021
CountryHK
Actively Trading

Frequently Asked Questions